The Crucial Role of Cholangiocytes in Cholangiopathies

키워드

참고문헌 (70)

1. Lazaridis KN, "The cholangiopathies: disorders of biliary epithelia", Gastroenterology, 127, pp.1565~1577 (2004)
2. Elsharkawy AM, "Nuclear factor-kappaB and the hepatic inflammation-fibrosis-cancer axis", Hepatology, 46, pp.590~597 (2007)
3. Kubo S, "Hepatolithiasis associated with cholangiocarcinoma", World J Surg, 19, pp.637~641 (1995)
4. Glaser SS, "Cholangiocyte proliferation and liver fibrosis", Expert Rev Mol Med, 11, pp.e7~ (2009)
5. Novo E, "Hepatic myofibroblasts: a heterogeneous population of multifunctional cells in liver fibrogenesis", Int J Biochem Cell Biol, 41, pp.2089~2093 (2009)
6. Fallowfield JA, "Therapeutic targets in liver fibrosis", Am J Physiol Gastrointest Liver Physiol, 300, pp.G709~G715 (2011)
7. Choi SS, "Epithelial-to-mesenchymal transitions in the liver", Hepatology, 50, pp.2007~2013 (2009)
8. Strazzabosco M, "Pathophysiology of cholangiopathies", J Clin Gastroenterol, 39(4 Suppl 2), pp.S90~S102 (2005)
9. Alvaro D, "New insights on the molecular and cell biology of human cholangiopathies", Mol Aspects Med, 29, pp.50~57 (2008)
10. Priester S, "Involvement of cholangiocyte proliferation in biliary fibrosis", World J Gastrointest Pathophysiol, 1, pp.30~37 (2010)
11. Pinzani M, "Liver fibrosis: from the bench to clinical targets", Dig Liver Dis, 36, pp.231~242 (2004)
12. Fabris L, "Epithelial-mesenchymal interactions in biliary diseases", Semin Liver Dis, 31, pp.11~32 (2011)
13. Roskams TA, "Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers", Hepatology, 39, pp.1739~1745 (2004)
14. Desmet VJ, "Ludwig symposium on biliary disorders. Part I. pathogenesis of ductal plate abnormalities", Mayo Clin Proc, 73, pp.80~89 (1998)
15. Friedman SL, "Mechanisms of hepatic fibrogenesis", Gastroenterology, 134, pp.1655~1669 (2008)
16. Jhandier MN, "Portal fibroblasts regulate the proliferation of bile duct epithelia via expression of NTPDase2", J Biol Chem, 280, pp.22986~22992 (2005)
17. Knittel T, "Rat liver myofibroblasts and hepatic stellate cells: different cell populations of the fibroblast lineage with fibrogenic potential", Gastroenterology, 117, pp.1205~1221 (1999)
18. Beaussier M, "Prominent contribution of portal mesenchymal cells to liver fibrosis in ischemic and obstructive cholestatic injuries", Lab Invest, 87, pp.292~303 (2007)
19. Forbes SJ, "A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis", Gastroenterology, 126, pp.955~963 (2004)
20. Asawa S, "Participation of bone marrow cells in biliary fibrosis after bile duct ligation", J Gastroenterol Hepatol, 22, pp.2001~2008 (2007)
21. Wells RG, "The epithelial-to-mesenchymal transition in liver fibrosis: here today, gone tomorrow?", Hepatology, 51, pp.737~740 (2010)
22. Cassiman D, "Hepatic stellate cell", myofibroblast subpopulations in fibrotic human and rat livers, 2002, pp.36, 200~209
23. Medina J, "Evidence of angiogenesis in primary biliary cirrhosis: an immunohistochemical descriptive study", J Hepatol, 42, pp.124~131 (2005)
24. Fallowfield JA, "Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis", J Immunol, 178, pp.5288~5295 (2007)
25. Duffield JS, "Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair", J Clin Invest, 115, pp.56~65 (2005)
26. Shimoda S, "Biliary epithelial cells and primary biliary cirrhosis: the role of liver-infiltrating mononuclear cells", Hepatology, 47, pp.958~965 (2008)
27. Popov Y, "Macrophage-mediated phagocytosis of apoptotic cholangiocytes contributes to reversal of experimental biliary fibrosis", Am J Physiol Gastrointest Liver Physiol, 298, pp.G323~G334 (2010)
28. Friedman SL, "Liver fibrosis: from bench to bedside", J Hepatol, 38(Suppl 1), pp.S38~S53 (2003)
29. Kruglov EA, "Secretion of MCP-1", CCL2 by bile duct epithelia induces myofibroblastic transdifferentiation of portal fibroblasts, 2006, pp.290, G765~G771
30. Hong F, "Hepatic stellate cells express functional CXCR4: role in stromal cell-derived factor-1alpha-mediated stellate cell activation", Hepatology, 49, pp.2055~2067 (2009)
31. Grappone C, "Expression of platelet-derived growth factor in newly formed cholangiocytes during experimental biliary fibrosis in rats", J Hepatol, 31, pp.100~109 (1999)
32. Gaudio E, "Vascular endothelial growth factor stimulates rat cholangiocyte proliferation via an autocrine mechanism", Gastroenterology, 130, pp.1270~1282 (2006)
33. Fabris L, "Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases", Hepatology, 43, pp.1001~1012 (2006)
34. Sedlaczek N, "Proliferating bile duct epithelial cells are a major source of connective tissue growth factor in rat biliary fibrosis", Am J Pathol, 158, pp.1239~1244 (2001)
35. Paradis V, "Effects and regulation of connective tissue growth factor on hepatic stellate cells", Lab Invest, 82, pp.767~774 (2002)
36. Gardini A, "Expression of connective tissue growth factor is a prognostic marker for patients with intrahepatic cholangiocarcinoma", Dig Liver Dis, 37, pp.269~274 (2005)
37. Liu Z, "Interleukin-6, hepatocyte growth factor, and their receptors in biliary epithelial cells during a type I ductular reaction in mice: interactions between the periductal inflammatory and stromal cells and the biliary epithelium", Hepatology, 28, pp.1260~1268 (1998)
38. Xia JL, "Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligation", Am J Pathol, 168, pp.1500~1512 (2006)
39. Omenetti A, "Hedgehog-mediated mesenchymal-epithelial interactions modulate hepatic response to bile duct ligation", Lab Invest, 87, pp.499~514 (2007)
40. Omenetti A, "Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans", J Clin Invest, 118, pp.3331~3342 (2008)
41. Omenetti A, "The hedgehog pathway regulates remodelling responses to biliary obstruction in rats", Gut, 57, pp.1275~1282 (2008)
42. Omenetti A, "Hedgehog activity, epithelial-mesenchymal transitions, and biliary dysmorphogenesis in biliary atresia", Hepatology, 53, pp.1246~1258 (2011)
43. Cheng JH, "Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis", Am J Physiol Gastrointest Liver Physiol, 294, pp.G39~G49 (2008)
44. Fabris L, "Analysis of liver repair mechanisms in Alagille syndrome and biliary atresia reveals a role for notch signaling", Am J Pathol, 171, pp.641~653 (2007)
45. Kalluri R, "Epithelial-mesenchymal transition and its implications for fibrosis", J Clin Invest, 112, pp.1776~1784 (2003)
46. Sicklick JK, "Evidence for epithelial-mesenchymal transitions in adult liver cells", Am J Physiol Gastrointest Liver Physiol, 291, pp.G575~G583 (2006)
47. Rygiel KA, "Epithelial-mesenchymal transition contributes to portal tract fibrogenesis during human chronic liver disease", Lab Invest, 88, pp.112~123 (2008)
48. Díaz R, "Evidence for the epithelial to mesenchymal transition in biliary atresia fibrosis", Hum Pathol, 39, pp.102~115 (2008)
49. Deng YH, "Analysis of biliary epithelial-mesenchymal transition in portal tract fibrogenesis in biliary atresia", Dig Dis Sci, 56, pp.731~740 (2011)
50. Lijin Zhao, "Epithelial-Mesenchymal Transitions of Bile Duct Epithelial Cells in Primary Hepatolithiasis", Journal of Korean Medical Science, 25(7), pp.1066~1070 (2010), 대한의학회
51. Robertson H, "Biliary epithelial-mesenchymal transition in posttransplantation recurrence of primary biliary cirrhosis", Hepatology, 45, pp.977~981 (2007)
52. Harada K, "Epithelial-mesenchymal transition induced by biliary innate immunity contributes to the sclerosing cholangiopathy of biliary atresia", J Pathol, 217, pp.654~664 (2009)
53. Chu AS, "Lineage tracing demonstrates no evidence of cholangiocyte epithelial-to-mesenchymal transition in murine models of hepatic fibrosis", Hepatology, 53, pp.1685~1695 (2011)
54. Taura K, "Hepatocytes do not undergo epithelial-mesenchymal transition in liver fibrosis in mice", Hepatology, 51, pp.1027~1036 (2010)
55. Scholten D, "Genetic labeling does not detect epithelial-to-mesenchymal transition of cholangiocytes in liver fibrosis in mice", Gastroenterology, 139, pp.987~998 (2010)
56. Iredale JP, "Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors", J Clin Invest, 102, pp.538~549 (1998)
57. Canbay A, "Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression", Hepatology, 38, pp.1188~1198 (2003)
58. Popov Y, "Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies", J Hepatol, 48, pp.453~464 (2008)
59. Patsenker E, "Inhibition of integrin alphavbeta6 on cholangiocytes blocks transforming growth factor-beta activation and retards biliary fibrosis progression", Gastroenterology, 135, pp.660~670 (2008)
60. Hennenberg M, "Hepatic and HSC-specific sorafenib effects in rats with established secondary biliary cirrhosis", Lab Invest, 91, pp.241~251 (2011)
61. Leclercq IA, "Limited therapeutic efficacy of pioglitazone on progression of hepatic fibrosis in rats", Gut, 55, pp.1020~1029 (2006)
62. Marra F, "Thiazolidinedione treatment inhibits bile duct proliferation and fibrosis in a rat model of chronic cholestasis", World J Gastroenterol, 11, pp.4931~4938 (2005)
63. Alpini G, "Bile acid feeding increased proliferative activity and apical bile acid transporter expression in both small and large rat cholangiocytes", Hepatology, 34, pp.868~876 (2001)
64. Alpini G, "Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte growth and secretion of BDL rats through activation of PKC alpha", Hepatology, 35, pp.1041~1052 (2002)
65. Alpini G, "Tauroursodeoxycholate inhibits human cholangiocarcinoma growth via Ca2+-, PKC-, and MAPK-dependent pathways", Am J Physiol Gastrointest Liver Physiol, 286, pp.G973~G982 (2004)
66. Fiorucci S, "The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis", Gastroenterology, 127, pp.1497~1512 (2004)
67. Trebicka J, "Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells", J Hepatol, 53, pp.702~712 (2010)
68. Boigk G, "Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats", Hepatology, 26, pp.643~649 (1997)
69. Raetsch C, "Pentoxifylline downregulates profibrogenic cytokines and procollagen I expression in rat secondary biliary fibrosis", Gut, 50, pp.241~247 (2002)
70. Issa R, "Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking", Gastroenterology, 126, pp.1795~1808 (2004)

관련 논문AI추천